SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001764013-21-000083
Filing Date
2021-08-12
Accepted
2021-08-12 16:37:24
Documents
3
Period of Report
2021-09-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A imvt-20210331defproxy.htm DEF 14A 604004
2 GRAPHIC immunovantinc_proxycard8-2b.jpg GRAPHIC 270002
3 GRAPHIC immunovantinc_proxycard8-2c.jpg GRAPHIC 182985
  Complete submission text file 0001764013-21-000083.txt   1229254
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-38906 | Film No.: 211168210
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences